RNAi inhibition of CTGF for treatment of ocular disorders

Details for Australian Patent Application No. 2005319279 (hide)

Owner Alcon, Inc.

Inventors Shepard, Allan R.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005319279

PCT Pub. Number WO2006/069037

Priority 60/638,705 23.12.04 US

Filing date 19 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 18 August 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/069037 Priority application(s): WO2006/069037

18 August 2011 Application Accepted

  Published as AU-B-2005319279

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319281-Process for dynamic routing of customer contacts to service providers in real time

2005319278-Anti-IL-12 antibodies, epitopes, compositions, methods and uses